BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1583715)

  • 1. Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis.
    Garber GE
    J Otolaryngol; 1992 Apr; 21(2):92-4. PubMed ID: 1583715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose therapy for esophageal candidiasis with fluconazole.
    Chave JP; Francioli P; Hirschel B; Glauser MP
    AIDS; 1990 Oct; 4(10):1034-5. PubMed ID: 2261120
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
    Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluconazole--a new antifungal agent].
    Dobloug JH
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1961-3. PubMed ID: 1509458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin: a new echinocandin antifungal.
    Joseph JM; Jain R; Danziger LH
    Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
    Gil A; Lavilla P; López Dupla M; Valencia E; Pintado V; Khamashta M; García Puig J; Ortiz-Vázquez J
    Med Clin (Barc); 1992 Apr; 98(16):612-7. PubMed ID: 1630165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients].
    Blancard A; Moulin-Traffort J; Regli P; Sarzier JM; Quilici M
    Pathol Biol (Paris); 1991 May; 39(5):534-8. PubMed ID: 1881690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
    Sow PS; Diop BM; Ndiaye I; Faye MA; Coll-Seck AM
    Dakar Med; 1993; 38(1):85-8. PubMed ID: 7882856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole prophylaxis in HIV disease, revisited.
    Bozzette SA
    Clin Infect Dis; 2005 Nov; 41(10):1481-2. PubMed ID: 16231261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluconazole found effective against candidiasis.
    Oncology (Williston Park); 1989 Nov; 3(11):112. PubMed ID: 2561879
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluconazole: a new antifungal agent.
    Kowalsky SF; Dixon DM
    Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
    J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationalizing prescribing for oral and oesophageal candidiasis.
    Taylor CB; Finlay R; Richardson C; Bunting P; Welch J
    Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.